Temple is a national leader in caring for patients with pulmonary hypertension, performing more than 100 pulmonary thromboendarterectomy (PTE) surgeries to date, the highest PTE surgical volume on the East Coast. The program’s rapid growth and national prominence is due to the highly-experienced and well-respected physicians and surgeons who make up Temple’s pulmonary hypertension team.
What is Pulmonary Hypertension?
Pulmonary hypertension occurs when the blood vessels within and/or leading to the lungs become narrowed, hardened, or blocked. This leads to high blood pressure and forces the right chamber of the heart, which pumps blood through the lungs, to work harder. If left untreated, it can eventually lead to right heart failure and even death.
Nationally Recognized Pulmonary Hypertension Doctors
Paul Forfia, MD
Director, Pulmonary Hypertension/Right Heart Failure and Pulmonary Thromboendarterectomy Program
Associate Professor of Medicine, Lewis Katz School of Medicine at Temple University
Dr. Forfia is recognized internationally for his ability to use echocardiographic readings to differentiate between arterial and non-arterial causes of PH. This more discriminating echo reading allows him to quickly rule out certain conditions, avoid unnecessary catheterizations, and streamline all the follow-up testing and treatment.
Anjali Vaidya, MD, FACC, FASE, FACP
Associate Director, Pulmonary Hypertension/Right Heart Failure and Pulmonary Thromboendarterectomy Program
Assistant Professor, Medicine, Lewis Katz School of Medicine at Temple University
Dr. Vaidya is nationally renowned for her expertise in all forms of pulmonary hypertension and right heart failure, including refined skill in using echocardiography to assess, monitor, and offer individually tailored therapy to patients with this complex disease. An active and published researcher and educator, Dr. Vaidya has extensive training and experience in helping patients with pulmonary hypertension and right-sided heart failure, including chronic thromboembolic pulmonary hypertension and other subtypes.
Yoshiya Toyoda, MD, PhD
Vice Chief, Cardiovascular Surgery
Surgical Director, Heart and Lung Transplantation
Director, Mechanical Circulatory Support
Professor of Surgery, Lewis Katz School of Medicine at Temple University
Dr. Toyoda is one of the nation’s most skilled and innovative cardiothoracic surgeons. Highly experienced in the surgical treatment of complex cardiac, pulmonary, or aortic conditions, his specialties include pulmonary thromboendarterectomy (PTE), heart and lung transplantation, mechanical circulatory support, valve repair/replacement, coronary artery bypass, and repair of adult congenital heart conditions.
Temple’s pulmonary thromboendarterectomy (PTE) program has achieved a low mortality rate of 3% – an impressive number considering the seriousness of pulmonary hypertension.
Thanks to PTE surgery, patients like Kevin are free of disease and living a healthier, more active life. Read Kevin's story.
Why Temple Health?
Consider the many reasons to choose Temple for treatment of pulmonary hypertension:
- One of the nation’s most experienced and skilled pulmonary hypertension medical teams
- The most active pulmonary thromboendarterectomy (PTE) program on the East Coast
- A low mortality rate for PTE surgery
- A wide range of advanced treatment options for patients who are not eligible for PTE surgery, including balloon pulmonary angioplasty
- Rapid patient appointments
In the following video, Paul Forfia, MD, discusses the diagnosis of CTEPH and how it can be treated with pulmonary thromboendarterectomy (PTE). Dr. Forfia's discussion of PTE includes the surgical process and recovery timeline: